Recent studies elucidate the potent protective effects of Ruscogenin against DSS-induced colitis, demonstrating its ability to alleviate the condition in mice by inhibiting the activation of the NLRP3 inflammasome and the caspase-1-dependent canonical pyroptosis. The gene discussed is NLRP3; the disease is colitis.